Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Jenburkt Pharmaceuticals Limited (NSE: JENBURPH), ISIN INE354A01013 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
JENBURPH last traded at ₹952.00 (-0.54%), with a 52-week range of ₹940.00 to ₹1321.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 46.62%, FIIs 0.00%, DIIs 0.12%, mutual funds 0.00%.
EquiSense Score (ECS): 48/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.